Molecular Psychiatry publishes cutting-edge work that advances our understanding of the biological mechanisms underlying psychiatric disorders and their treatment. The journal emphasizes studies at the interface of preclinical and clinical research, spanning cellular, molecular, integrative, imaging, and psychopharmacological levels. In addition to fundamental mechanistic research, Molecular Psychiatry seeks to highlight high-quality clinical studies, including observational research, biomarker investigations, and clinical trials, that directly translate biological insights into advances in patient care. By fostering connections between basic science and clinical application, the journal serves as a forum for work that bridges laboratory discoveries with therapeutic innovation and improved outcomes for individuals with psychiatric disorders.